These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9815574)

  • 61. Detection of HuD transcripts by means of reverse transcriptase and polymerase chain reaction: implications for the detection of minimal residual disease in patients with small cell lung cancer.
    Torà M; Barberá VM; Real FX
    Cancer Lett; 2000 Dec; 161(2):157-64. PubMed ID: 11090964
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intratumoral anti-HuD immunotoxin therapy for small cell lung cancer and neuroblastoma.
    Ehrlich D; Wang B; Lu W; Dowling P; Yuan R
    J Hematol Oncol; 2014 Dec; 7():91. PubMed ID: 25523825
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tissue distribution of pathological lesions and Hu antigen expression in paraneoplastic sensory neuronopathy.
    Ichimura M; Yamamoto M; Kobayashi Y; Kawakami O; Niimi Y; Hattori N; Nagamatsu M; Hashizume Y; Sobue G
    Acta Neuropathol; 1998 Jun; 95(6):641-8. PubMed ID: 9650757
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gene elav of Drosophila melanogaster: a prototype for neuronal-specific RNA binding protein gene family that is conserved in flies and humans.
    Yao KM; Samson ML; Reeves R; White K
    J Neurobiol; 1993 Jun; 24(6):723-39. PubMed ID: 8331337
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hel-N2: a novel isoform of Hel-N1 which is conserved in rat neural tissue and produced in early embryogenesis.
    King PH
    Gene; 1994 Dec; 151(1-2):261-5. PubMed ID: 7828887
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome.
    Raggi CC; Maggi M; Renzi D; Calabrò A; Bagnoni ML; Scaruffi P; Tonini GP; Pazzagli M; De Bernardi B; Bernini G; Serio M; Orlando C
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3866-73. PubMed ID: 11061551
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The RNA-binding protein HuD regulates neuronal cell identity and maturation.
    Akamatsu W; Fujihara H; Mitsuhashi T; Yano M; Shibata S; Hayakawa Y; Okano HJ; Sakakibara S; Takano H; Takano T; Takahashi T; Noda T; Okano H
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4625-30. PubMed ID: 15764704
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The human kallikrein gene family: new biomarkers for ovarian cancer.
    Yousef GM; Diamandis EP
    Cancer Treat Res; 2009; 149():165-87. PubMed ID: 19763436
    [No Abstract]   [Full Text] [Related]  

  • 69. Multiple target molecular monitoring of bone marrow and peripheral blood samples from patients with localized neuroblastoma and healthy donors.
    Corrias MV; Haupt R; Carlini B; Cappelli E; Giardino S; Tripodi G; Tonini GP; Garaventa A; Pistoia V; Pistorio A
    Pediatr Blood Cancer; 2012 Jan; 58(1):43-9. PubMed ID: 21254375
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Detection of cell-free RNA in children with neuroblastoma and comparison with that of whole blood cell RNA.
    Corrias MV; Pistorio A; Cangemi G; Tripodi G; Carlini B; Scaruffi P; Fardin P; Garaventa A; Pistoia V; Haupt R
    Pediatr Blood Cancer; 2010 Jul; 54(7):897-903. PubMed ID: 20405510
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HuR, a novel target of anti-Hu antibodies, is expressed in non-neural tissues.
    Nabors LB; Furneaux HM; King PH
    J Neuroimmunol; 1998 Dec; 92(1-2):152-9. PubMed ID: 9916890
    [TBL] [Abstract][Full Text] [Related]  

  • 72. RNA-binding analyses of HuC and HuD with the VEGF and c-myc 3'-untranslated regions using a novel ELISA-based assay.
    King PH
    Nucleic Acids Res; 2000 Apr; 28(7):E20. PubMed ID: 10710437
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression of mRNA for the elav-like neural-specific RNA binding protein, HuD, during nervous system development.
    Clayton GH; Perez GM; Smith RL; Owens GC
    Brain Res Dev Brain Res; 1998 Aug; 109(2):271-80. PubMed ID: 9729424
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Selection of a subset of mRNAs from combinatorial 3' untranslated region libraries using neuronal RNA-binding protein Hel-N1.
    Gao FB; Carson CC; Levine T; Keene JD
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11207-11. PubMed ID: 7972035
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tumors of the neuroblastoma group.
    Shimada H
    Pathology (Phila); 1993; 2(1):43-59. PubMed ID: 9420930
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High expressions of neuronatin isoforms in favorable neuroblastoma.
    Higashi M; Tajiri T; Kinoshita Y; Tatsuta K; Souzaki R; Maehara Y; Suita S; Taguchi T
    J Pediatr Hematol Oncol; 2007 Aug; 29(8):551-6. PubMed ID: 17762496
    [TBL] [Abstract][Full Text] [Related]  

  • 77. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal.
    Szabo A; Dalmau J; Manley G; Rosenfeld M; Wong E; Henson J; Posner JB; Furneaux HM
    Cell; 1991 Oct; 67(2):325-33. PubMed ID: 1655278
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Developmental gene expression of sympathetic nervous system tumors reflects their histogenesis.
    Hoehner JC; Hedborg F; Eriksson L; Sandstedt B; Grimelius L; Olsen L; Påhlman S
    Lab Invest; 1998 Jan; 78(1):29-45. PubMed ID: 9461120
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ha-ras p21 in neuroblastoma: a new marker in prediction of patient outcome.
    Tanaka T
    Prog Clin Biol Res; 1994; 385():275-80. PubMed ID: 7972221
    [No Abstract]   [Full Text] [Related]  

  • 80. [Molecular biology markers of neuroblastoma as the basis for a therapy concept].
    Girgert R; Treuner J; Schweizer P
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():1053-5. PubMed ID: 9101780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.